panitumumab,bevacizumab
amgen,roche
['rectal', 'colorectal', 'bevacizumab', 'panitumumab']
panitumumab vs bevacizumab added to standard first-line chemotherapy and overall survival among patients with ras wild-type, left-sided metastatic colorectal cancer: a randomized clinical trial, from , free to read online during #asco23. 
Home of @JAMA_Current, @JAMANetworkOpen, @JAMAHealthForum, & 10 specialty journals that publish science and opinion shaping #medicine today and into the future.